Kyowa Kirin
Ernesto Aycardi is an experienced pharmaceutical executive currently serving as Head Global Development Organization and Chief Development Officer at Kyowa Kirin Co., Ltd. since April 2021. Previously, Ernesto held the position of Chief Medical Officer at Xenon Pharmaceuticals Inc. from March 2018 to April 2021. Their extensive background includes roles such as Vice President at Teva Pharmaceuticals, where responsibilities encompassed global clinical trial execution and data management, Vice President and Therapeutical Area Head at EMD Serono, Inc., and various leadership positions in clinical development at Biogen Idec and Merck & Co., where Ernesto oversaw multiple therapeutic areas including neurology and pain management. Ernesto began their medical career as a clinical neurologist at CAFAM and Hospital Militar Central. Academic credentials include a degree from Universidad Nacional de Colombia.
This person is not in any offices
Kyowa Kirin
5 followers
Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of technologies for antibody drug creation, among others. It also involved in the contracting, retail and wholesale, and insurance agency businesses. The Biochemical segment manufactures and sells medical and industrial materials, mainly amino and nucleic acids, and healthcare products. This segment also designs and constructs facilities.